Optometry News

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Carlos Quezada-Ruiz, MD, FASRS, of Genentech/Roche shares an update on Susvimo and the port delivery platform.

Although similarities exist between ocular graft-versus-host disease and dry eye disease, more research is needed to improve diagnostic criteria and treatment, according to a review in Clinical & Experimental Ophthalmology.

Implantation of a capsular tension ring was shown in a study to reduce IOL decentration and tilt in highly myopic eyes with an axial length of 30 mm or longer.

The Twin Cities Ocular Surface Disease Symposium, Sept. 7 and 8, will feature discussions about dry eye comorbidities, standards of care and more, Ahmad M. Fahmy, OD, FAAO, DiplABO, the event’s founder, told Healio.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Doug Faunce, PhD, reviews AbbVie’s ongoing efforts in the eye care field.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Charles Semba, MD, chief medical officer of Eluminex Biosciences, discusses a trispecific antibody for refractory diabetic macular edema.

Melatonin use was associated with a decreased risk for both development and progression of age-related macular degeneration among adults aged 50 years or older, according to a study published in JAMA Ophthalmology.

The current prior authorization process required for anti-VEGF medications leads to treatment delays, increased health care costs due to administrative burdens and potentially worse visual outcomes.

Bloomberg Philanthropies announced that it has donated $1 billion to make Johns Hopkins University’s medical school free for most of its students seeking an MD.

A dexamethasone 0.4 mg intracanalicular insert was linked to greater improvement in corneal and conjunctival staining vs. a sham collagen plug among patients with aqueous-deficient dry eye, although it may increase IOP, research showed.